Breast Radiology Reporting - 1st STU ballot - Local Development build (v0.2.0). See the Directory of published versions

BiRads(r) Assessment Category Codes CodeSystem - TTL Representation

(back to description)

Raw ttl

Source view

@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "BiRadsAssessmentCategoriesCS"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>BiRads(r) Assessment Category Codes CodeSystem</h2><div><p>BiRads(r) Assessment Category code system.</p>\n</div><p>This code system http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">Category0<a name=\"BiRadsAssessmentCategoriesCS-Category0\"> </a></td><td>Category 0 (Incomplete)</td><td>Need additional Imaging Evaluation and/or prior Mammograms \r\nfor comparison. \r\nRecall for additional imaging and/or comparison with \r\nprior examination(s) \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category2<a name=\"BiRadsAssessmentCategoriesCS-Category2\"> </a></td><td>Category 2 (Benign)</td><td>This is a normal assessment. \r\nBenign refers to a condition, tumor, or growth that \r\nis not cancerous. \r\nThis means that it does not spread to other parts \r\nof the body. \r\nIt does not invade nearby tissue. \r\nEssentially 0% likelihood of malignancy. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category3<a name=\"BiRadsAssessmentCategoriesCS-Category3\"> </a></td><td>Category 3 (Probably Benign)</td><td>A finding assessed using this category should have \r\na &lt;= 2% likelihood of malignancy, \r\nbut greater than the essentially 0% likelihood of \r\nmalignancy of a characteristically \r\nbenign finding. \r\nA probably benign finding is not expected to change \r\nover the suggested period of \r\nimaging surveillance, but the interpreting physician \r\nprefers to establish stability \r\nof the finding before recommending management limited \r\nto routine mammography screening. \r\nSix month follow-up and/or \r\nsurveillance mammography is recommended. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category4<a name=\"BiRadsAssessmentCategoriesCS-Category4\"> </a></td><td>Category 4 (Suspicious)</td><td>This category is reserved for findings that do not \r\nhave the classic appearance of \r\nmalignancy but are sufficiently suspicious to justify \r\na recommendation for biopsy. \r\nThere is a 2% likelihood of malignancy (cancer). \r\nAlmost all recommendations for breast interventional \r\nprocedures will come from assessments \r\nmade using \r\nthis category. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category4A<a name=\"BiRadsAssessmentCategoriesCS-Category4A\"> </a></td><td>Category 4A (Low suspicion)</td><td>Low suspicion for malignancy. \r\nA malignant finding is not suspected. \r\nA biopsy or other test will likely still be performed \r\nin order to determine. \r\nTissue diagnosis may be recommended. \r\nSix month follow-up and/or surveillance mammography \r\nis recommended. \r\nLikelihood of malignancy is &gt; 2% to &lt;= 10% likelihood \r\nof malignancy. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category4B<a name=\"BiRadsAssessmentCategoriesCS-Category4B\"> </a></td><td>Category 4B (Moderate suspicion)</td><td>Category 4B: Moderate suspicion for malignancy. \r\nIt warrants radiologic and pathologic correlation \r\nafter tissue diagnosis. \r\nLikelihood of malignancy is &gt; 10% to &lt;= 50% likelihood \r\nof \r\nmalignancy. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category4C<a name=\"BiRadsAssessmentCategoriesCS-Category4C\"> </a></td><td>Category 4C (High suspicion)</td><td>Category 4C: High suspicion for \r\nmalignancy. \r\nIncludes findings that have a high suspicion of malignancy \r\nbut that are not highly \r\nsuggestive of malignancy (category 5). \r\nTissue Diagnosis is highly recommended. \r\nRange for likelihood of malignancy is &gt; 50% to &lt; \r\n95% likelihood of malignancy. \r\nIt is more likely malignant versus benign. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category5<a name=\"BiRadsAssessmentCategoriesCS-Category5\"> </a></td><td>Category 5 (Highly Suggestive of Malignancy)</td><td>Highly Suggestive of Malignancy. \r\nAlmost certainly predictive of breast cancer with \r\na \r\nvalue of at least 95%. \r\nTissue Diagnosis is highly recommended or required. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr><tr><td style=\"white-space:nowrap\">Category6<a name=\"BiRadsAssessmentCategoriesCS-Category6\"> </a></td><td>Category 6 (Known Biopsy-Proven Malignancy)</td><td>Known Biopsy-Proven Malignancy. \r\nSurgical excision when clinically \r\nappropriate. \r\nThis category is only used for findings on a mammogram \r\nthat have already been shown to be cancer by a previous \r\nbiopsy. \r\nMammograms may be used in this way to see how well \r\nthe cancer is responding to treatment. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM.</td></tr></table></div>"
  ];
  fhir:CodeSystem.url [ fhir:value "http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS"];
  fhir:CodeSystem.version [ fhir:value "0.2.0"];
  fhir:CodeSystem.name [ fhir:value "BiRadsAssessmentCategoriesCS"];
  fhir:CodeSystem.title [ fhir:value "BiRads(r) Assessment Category Codes CodeSystem"];
  fhir:CodeSystem.status [ fhir:value "draft"];
  fhir:CodeSystem.date [ fhir:value "2019-11-01T00:00:00+00:00"^^xsd:dateTime];
  fhir:CodeSystem.publisher [ fhir:value "Hl7 - Clinical Interoperability Council"];
  fhir:CodeSystem.contact [
     fhir:index 0;
     fhir:ContactDetail.telecom [
       fhir:index 0;
       fhir:ContactPoint.system [ fhir:value "url" ];
       fhir:ContactPoint.value [ fhir:value "http://hl7.org/Special/committees/cic" ]     ]
  ];
  fhir:CodeSystem.description [ fhir:value "BiRads(r) Assessment Category code system."];
  fhir:CodeSystem.jurisdiction [
     fhir:index 0;
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "http://unstats.un.org/unsd/methods/m49/m49.htm" ];
       fhir:Coding.code [ fhir:value "001" ]     ]
  ];
  fhir:CodeSystem.caseSensitive [ fhir:value "true"^^xsd:boolean];
  fhir:CodeSystem.content [ fhir:value "complete"];
  fhir:CodeSystem.count [ fhir:value "9"^^xsd:nonNegativeInteger];
  fhir:CodeSystem.concept [
     fhir:index 0;
     fhir:CodeSystem.concept.code [ fhir:value "Category0" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 0 (Incomplete)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "Need additional Imaging Evaluation and/or prior Mammograms \r\nfor comparison. \r\nRecall for additional imaging and/or comparison with \r\nprior examination(s) \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 1;
     fhir:CodeSystem.concept.code [ fhir:value "Category2" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 2 (Benign)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "This is a normal assessment. \r\nBenign refers to a condition, tumor, or growth that \r\nis not cancerous. \r\nThis means that it does not spread to other parts \r\nof the body. \r\nIt does not invade nearby tissue. \r\nEssentially 0% likelihood of malignancy. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 2;
     fhir:CodeSystem.concept.code [ fhir:value "Category3" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 3 (Probably Benign)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "A finding assessed using this category should have \r\na <= 2% likelihood of malignancy, \r\nbut greater than the essentially 0% likelihood of \r\nmalignancy of a characteristically \r\nbenign finding. \r\nA probably benign finding is not expected to change \r\nover the suggested period of \r\nimaging surveillance, but the interpreting physician \r\nprefers to establish stability \r\nof the finding before recommending management limited \r\nto routine mammography screening. \r\nSix month follow-up and/or \r\nsurveillance mammography is recommended. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 3;
     fhir:CodeSystem.concept.code [ fhir:value "Category4" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 4 (Suspicious)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "This category is reserved for findings that do not \r\nhave the classic appearance of \r\nmalignancy but are sufficiently suspicious to justify \r\na recommendation for biopsy. \r\nThere is a 2% likelihood of malignancy (cancer). \r\nAlmost all recommendations for breast interventional \r\nprocedures will come from assessments \r\nmade using \r\nthis category. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 4;
     fhir:CodeSystem.concept.code [ fhir:value "Category4A" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 4A (Low suspicion)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "Low suspicion for malignancy. \r\nA malignant finding is not suspected. \r\nA biopsy or other test will likely still be performed \r\nin order to determine. \r\nTissue diagnosis may be recommended. \r\nSix month follow-up and/or surveillance mammography \r\nis recommended. \r\nLikelihood of malignancy is > 2% to <= 10% likelihood \r\nof malignancy. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 5;
     fhir:CodeSystem.concept.code [ fhir:value "Category4B" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 4B (Moderate suspicion)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "Category 4B: Moderate suspicion for malignancy. \r\nIt warrants radiologic and pathologic correlation \r\nafter tissue diagnosis. \r\nLikelihood of malignancy is > 10% to <= 50% likelihood \r\nof \r\nmalignancy. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 6;
     fhir:CodeSystem.concept.code [ fhir:value "Category4C" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 4C (High suspicion)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "Category 4C: High suspicion for \r\nmalignancy. \r\nIncludes findings that have a high suspicion of malignancy \r\nbut that are not highly \r\nsuggestive of malignancy (category 5). \r\nTissue Diagnosis is highly recommended. \r\nRange for likelihood of malignancy is > 50% to < \r\n95% likelihood of malignancy. \r\nIt is more likely malignant versus benign. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 7;
     fhir:CodeSystem.concept.code [ fhir:value "Category5" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 5 (Highly Suggestive of Malignancy)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "Highly Suggestive of Malignancy. \r\nAlmost certainly predictive of breast cancer with \r\na \r\nvalue of at least 95%. \r\nTissue Diagnosis is highly recommended or required. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ], [
     fhir:index 8;
     fhir:CodeSystem.concept.code [ fhir:value "Category6" ];
     fhir:CodeSystem.concept.display [ fhir:value "Category 6 (Known Biopsy-Proven Malignancy)" ];
     fhir:CodeSystem.concept.definition [ fhir:value "Known Biopsy-Proven Malignancy. \r\nSurgical excision when clinically \r\nappropriate. \r\nThis category is only used for findings on a mammogram \r\nthat have already been shown to be cancer by a previous \r\nbiopsy. \r\nMammograms may be used in this way to see how well \r\nthe cancer is responding to treatment. \r\n[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] \r\n\r\nValid for the following modalities: MG US MRI NM." ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.